SRT Therapy Skin Cancer Treatment in Belleville, IL

SRT Superficial Radiation Therapy in Belleville, IL for Basal Cell Carcinoma, Squamous Cell Carcinoma & Keloids
SRT Skin Treatment is Available at Dermassociates, Ltd.

 

 

What is smart in skin cancer treatment? SRT (superficial radiotherapy) is smart.

Skin cancer, the non-melanoma types (basal and squamous cell) can now be treated without needles, anesthetics, bleeding, or surgery with equivalent cure rate. Dermassociates LTD., dermatologist in Belleville, IL, offers SRT.

This is especially important for patients who take blood thinner medications, older patients with fragile skin, thick skin areas that could leave unsightly surgical scars and patients who wish to avoid surgery for any reason.

The radiation used for this treatment is specific to location and size of the cancer. The dose schedule allows sufficient energy and dose to kill tumor cells while sparing normal tissues. Spaced over multiple treatments, even the most difficult cancers can be eradicated with normal tissue spared and no change in lifestyle. There is no scarring caused from the radiotherapy, only possible minimal scarring from the tumor.

In addition to skin cancer treatment, SRT is used for Keloid treatment providing greater than 90% curative rates on ONLY 3 treatments.

Medicare and most insurances cover all or most of the SRT treatment. SRT is a viable alternative with considering for your skin cancer and keloid treatment.

The Benefits of SRT Skin Cancer Treatment

SRT-100™ provides patients and physicians with a safe and effective treatment option using a precise dose of radiation that offers minimal side effects and many benefits, including:

Highly Effective Non-Surgical Skin Cancer Treatment

95%+ Cure Rate that Rivals Surgery

Non-Surgical Skin Cancer Treatment

No Anesthesia, Cutting, Bleeding, Pain, or Unsightly Scars

Skin Cancer Treatment with No Downtime

No Downtime or Lifestyle Restrictions

Skin Cancer Treatment without Reconstructive Surgery

No Need for Post-Treatment Reconstructive Surgery

SRT Frequently Asked Questions

What kind of conditions can be treated with the SRT-100™?
  • Keloid scars
  • Basal cell carcinoma
  • Squamous cell carcinoma
  • Metatypical carcinoma
  • Cutaneous appendage carcinoma
  • Actinic keratosis
  • Kaposi’s sarcoma
What is the cure rate of basal and squamous cell skin cancer when treated with the SRT-100™?

When it comes to treating skin cancer (basal and squamous cell carcinoma) with radiation therapy, SRT – 100™ is comparable to surgical options and is 95 percent plus effective in curing basal and squamous cell skin cancer.

What is the cure rate for keloids with the SRT-100™?

The SRT-100™ is very effective in treating keloids and boasts a cure rate of 94 percent plus.

How long is a typical treatment?

Depending on the treatment protocol your physician chooses for your particular case, you may need several treatments per week for up to several weeks.

Is the SRT-100™ a safe treatment option?

The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.

What should I expect from SRT-100™ treatment?

You should expect the same results as surgery, but with these additional benefits:

  • No pain
  • No anesthesia
  • No cutting
  • No bleeding
  • No stitching
  • No scarring
  • No interruption of lifestyle
  • No reconstructive surgery
Why is the SRT-100™ a viable alternative to surgery?

The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.

Will I need reconstructive surgery post treatment?

No. The SRT-100™ is a non-invasive procedure. Since it does not require incisions, patients are not left with any scarring post-treatment.

Is the SRT-100™ cleared by the FDA?

Yes, the SRT-100™ has been cleared by the Federal Drug Administration for use on the entire body—making it especially effective in the treatment of non-melanoma skin cancer and keloid scars.

Learn more about Informed Consent and what it involves.

Patient Outcomes

Basal Cell Carcinoma Right Tibial Inferior

Skin Cancer Biopsy in Belleville

Biopsy

Final Treatment

Final Treatment

30 Days Later

30 Days Later

Squamous Cell Carcinoma Right Anterior Scalp Lateral

Skin Cancer Biopsy in Belleville, IL

Biopsy

Final Laser Treatment

Final Treatment

30 Days Later

30 Days Later